{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:57:00Z","timestamp":1787007420648,"version":"build-2736575974"},"reference-count":73,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/17425255.2023.2283524","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T04:30:15Z","timestamp":1700109015000},"page":"979-990","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK\/PD modelling"],"prefix":"10.1080","volume":"19","author":[{"given":"Xiang","family":"Gao","sequence":"first","affiliation":[{"name":"Preclinical Development, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Diep","sequence":"additional","affiliation":[{"name":"Preclinical Development, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Norris","sequence":"additional","affiliation":[{"name":"Preclinical Development, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie Z.","family":"Yu","sequence":"additional","affiliation":[{"name":"Preclinical Development, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Geary","sequence":"additional","affiliation":[{"name":"Preclinical Development, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j\/jbc.2021.100416"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.1998.10647954"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.004"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.06.036"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx818"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku531"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40495-020-00212-x"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1770"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2022.2133649"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-021-09761-0"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/108729001750072092"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.769538"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.11.1419"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425250902877680"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0224-4"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1621838"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2011.0299"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.11.005"},{"key":"e_1_3_6_21_1","first-page":"305","article-title":"Pharmacokinetic\/Pharmacodynamic properties of phosphorothioate 2\u2019 - O-(2-methoxyethyl)-modified antisense oligonucleotides in animals and man","volume":"2","author":"Geary RS","year":"2007","unstructured":"Geary RS, Yu RZ, Siwkowski A, et al. Pharmacokinetic\/Pharmacodynamic properties of phosphorothioate 2\u2019 - O-(2-methoxyethyl)-modified antisense oligonucleotides in animals and man. Antisense Drug Technol, Princ, Strategies And Appl. 2007;2:305\u2013326.","journal-title":"Antisense Drug Technol, Princ, Strategies And Appl"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2022.069"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0075-7"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.85"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmat3765"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.081729"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12945"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200948010-00003"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.08.012"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2015.0588"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645080-00003"},{"key":"e_1_3_6_32_1","first-page":"115","article-title":"A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer","volume":"9","author":"Adjei AA","year":"2003","unstructured":"Adjei AA, Dy GK, Erlichman C, et al. A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer. Clin Cancer Res Official J Am Assoc Cancer Res. 2003;9:115\u2013123.","journal-title":"Clin Cancer Res Official J Am Assoc Cancer Res"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.01.008"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.69"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900907"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.212407"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1235"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci,insight.135633"},{"key":"e_1_3_6_39_1","unstructured":"US Food and Drug Administration Guidance for Industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. 2005. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/estimating-maximum-safe-starting-dose-initial-clinical-trials-therapeutics-adult-healthy-volunteers"},{"issue":"5","key":"e_1_3_6_40_1","first-page":"383","article-title":"Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides","volume":"12","author":"Geary RS","year":"1997","unstructured":"Geary RS, Leeds JM, Henry SP, et al. Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides. Anticancer Drug Des Internet. 1997;12(5):383\u2013393.","journal-title":"Anticancer Drug Des"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2020.0911"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623313505781"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2016.0623"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2020.0867"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04011.x"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010027"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31408-8"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70061-9"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.157.2.4048444"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1171315"},{"issue":"7","key":"e_1_3_6_51_1","first-page":"1982","article-title":"A primate model for study of methotrexate pharmacokinetics in the central nervous system","volume":"37","author":"Poplack DG","year":"1977","unstructured":"Poplack DG, Bleyer WA, Wood JH, et al. A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res [Internet]. 1977;37(7 Pt 1):1982\u20131985.","journal-title":"Cancer Res"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-012-2732-7"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/11.4.335"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-014-9398-5"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15468"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2019.0822"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000805"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-012-9280-2"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182536211"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2338"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.884"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12663"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.010909.105654"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010716-104846"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1373924"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1992382"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr089"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1171"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2018.0727"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019181796"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13461"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.06.009"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.05.084"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.10.011"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13154"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2023.2283524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:08:12Z","timestamp":1727201292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2023.2283524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/17425255.2023.2283524"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2023.2283524","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}